PTGS2 and neurodegenerative disease: Kyungok-go has also been identified as a potential treatment for neurological inflammation and neurodegenerative diseases because it suppressed nitric oxide, inducible nitric oxide synthase, cyclooxygenase 2, and various cytokines that occur during inflammation in BV2 cells, a microglial mouse cell line [41].